The efficacy of botulinum toxin type A treatment and surgery for acute acquired comitant esotropia
- Resource Type
- article
- Authors
- Yipao Li; Luyao Tong; Yuanyuan Chen; BinJun Zhang; Minghui Wan; Xiangping Yin; Fang Zhang
- Source
- Frontiers in Medicine, Vol 10 (2023)
- Subject
- acute acquired comitant esotropia
AACE
botulinum toxin type A
BTXA
surgical outcome acute acquired comitant esotropia
surgical outcome
Medicine (General)
R5-920
- Language
- English
- ISSN
- 2296-858X
AimTo compare the long-term efficiency of botulinum toxin type A (BTXA) injection and surgery on acute acquired comitant esotropia (AACE).MethodsThis retrospective study enrolled patients with AACE from January 2020 to August 2022. The horizontal angle of deviation pre- and post-treatment was measured. Deviations in BTXA and surgical treatment were compared. The BTXA group was divided into adequate treatment (AT) and inadequate treatment (inAT) subgroup based on the deviation of no more than 4 prism diopters (at near and distance) or temporary exotropia at the 2 week follow-up. The two subgroups were compared to determine the long-term efficacy of BTXA treatment.ResultsNinety-two patients with AACE were included. Follow-up was 6 months. The deviations of the surgery and BTXA group were significantly smaller at the 6 month follow-up than at pre-treatment (p